US FDA panel unanimously backs expanded use of J&J's CAR-T therapy-April 2024-www.financetom.com

US FDA panel unanimously backs expanded use of J&J's CAR-T therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA panel unanimously backs expanded use of J&J's CAR-T therapy

Mar 15, 2024 10:15 AM

March 15 (Reuters) - Advisers to the U.S. Food and Drug

Administration on Friday unanimously voted in favor of allowing

the use of Johnson & Johnson's ( JNJ ) cell therapy as an

earlier treatment for a type of blood cancer.

All eleven voting members of the panel agreed that benefits

of J&J's Carvykti outweighed the risks of the therapy when given

as an earlier treatment.

Previous page： ING Comments on Euro, Sterling, Hungary's Forint Next page： Biotech Septerna aims to raise up to $186 million in US IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

ING Comments on Euro, Sterling, Hungary's Forint

Oct 21, 2024

06:15 AM EDT, 10/21/2024 (MT Newswires) -- EUR/USD is licking its wounds after a tough week, said ING. According to the bank, the two key drivers have been: a) the market's repricing of a potential United States presidential candidate Donald Trump victory presaging a potentially tariff-inflicted period for world trade, and b) European Central Bank President Christine Lagarde throwing more...

Biotech Septerna aims to raise up to $186 million in US IPO

Oct 21, 2024

Oct 21 (Reuters) - Biotechnology company Septerna said on Monday it is aiming to raise up to $186 million in its initial public offering in the United States. ...

GM, Ford brace for investor scrutiny over pricing power, EV losses

Oct 21, 2024

(Reuters) - General Motors ( GM ) and Ford Motor ( F ) will likely have a tough time convincing investors when they report results that Detroit's pricing power for gasoline cars is still strong and losses from their EV ventures are dwindling. GM is set to release its results for the July to September period on Oct. 22, while...

Exclusive-Qatar LNG sales to key Asian markets confronted by US, UAE rivalry

Oct 21, 2024

(Reuters) - Qatar is finding it hard to agree new deals to supply liquefied natural gas (LNG) to Japan and South Korea as rising competition from the U.S. and elsewhere with more flexible contract terms challenges Doha's decades-old dominance of the market. Qatar was once the top LNG supplier to Japan and South Korea, but buyers are showing preference for...